NCT03703193

Brief Summary

Spasticity and pain, particularly int he shoulder region, are the most common impairments experienced by subjects who had experienced a stroke. There is preliminary evidence supporting the role of dry needling for spasticity in patients who had suffered from a stroke. Few data exists on the effects on shoulder pain. In addition, it has been shown that application of dry needling induces post-needling soreness in individuals with musculoskeletal pain. No previous study has investigated the presence and the duration of post-needling soreness in individuals who had experienced a stroke.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable stroke

Timeline
Completed

Started Oct 2018

Shorter than P25 for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 6, 2018

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 11, 2018

Completed
8 days until next milestone

Study Start

First participant enrolled

October 19, 2018

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 21, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 21, 2018

Completed
Last Updated

December 28, 2018

Status Verified

December 1, 2018

Enrollment Period

2 months

First QC Date

October 6, 2018

Last Update Submit

December 27, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Changes in post-dry needling pain intensity with a numerical pain rate scale before and after the intervention

    A Numerical Pain Rate Scale (NPRS, 0-10) will be used to record post-dry needling soreness in the targeted area

    Baseline, 24 hours (1 day) after and 72 hours (3 days) after treatment the intervention

Secondary Outcomes (2)

  • Changes in spontaneous shoulder pain with a numerical pain rate scale before and after the intervention

    Baseline, 72 hours (3 days) and 168 hours (7 days) after treatment the intervention

  • Presence of active trigger points in the shoulder musculature

    Baseline, 72 hours (3 days) and 168 hours (7 days) after treatment the intervention

Study Arms (2)

Dry needling

EXPERIMENTAL

The experimental group will receive a single session of modulatory interventions combined with a single session of dry needling into the shoulder muscles which active trigger points will reproduce the shoulder pain symptoms.

Other: Dry Needling

Physical Therapy

ACTIVE COMPARATOR

This group will receive a single session of modulatory interventions targeting modulation of central nervous system.

Other: Physical Therapy

Interventions

A single session of modulatory interventions combined with a single session of dry needling into the shoulder muscles which active trigger points will reproduce the shoulder pain symptoms.

Dry needling

A single session of modulatory interventions targeting modulation of central nervous system.

Physical Therapy

Eligibility Criteria

Age30 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • first-ever unilateral stroke;
  • hemiplegia resulting from stroke;
  • age between 30 and 60 years old;
  • presence of hypertonicity in the upper extremity;
  • pain symptoms in the shoulder
  • active trigger points in the shoulder muscles reproducing the shoulder pain symptoms

You may not qualify if:

  • recurrent stroke;
  • absence of active trigger points in the shoulder muscles reproducing shoulder symptoms
  • previous treatment with nerve blocks, motor point injections with neurolytic agents for spasticity at any time;
  • previous treatment with botulinum toxin-A in the 6 months prior the study;
  • severe cognitive deficits;
  • other neurologic diseases,
  • underlying complex medical conditions, e.g., heart conditions, unstable hypertension, fracture
  • fear to needles;
  • any contraindication for deep dry needling, e.g., anticoagulants, infections, bleeding, or psychotic.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

César Fernández-de-las-Peñas

Alcorcón, Madrid, 28922, Spain

Location

MeSH Terms

Conditions

Stroke

Interventions

Dry NeedlingPhysical Therapy Modalities

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeuticsRehabilitation

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Department

Study Record Dates

First Submitted

October 6, 2018

First Posted

October 11, 2018

Study Start

October 19, 2018

Primary Completion

December 21, 2018

Study Completion

December 21, 2018

Last Updated

December 28, 2018

Record last verified: 2018-12

Locations